Summit is listed on AIM, a market of the London Stock Exchange and the NASDAQ Global Market. More detailed share information is provided below.
Issued share capital: 70,629,352 Ordinary Shares of 1p nominal value
The percentage of Ordinary Shares not being held in public hands is 28.3%.
Shares held in treasury: Nil Ordinary shares.
There are no restrictions on the transfer of Ordinary Shares in the Company.
|Shares Listed:||Ordinary Shares|
|Index||FTSE AIM All Share|
|Sector:||Pharmaceutical & Biotechnology|
|Shares Listed:||American Depositary Shares (ADS)|
|Market:||NASDAQ Global Market|
|Depositary Bank:||Bank of New York Mellon|
Each ADS represents five Ordinary Shares.
Information correct as at 17 November 2017
Summit had been notified of the following holdings of more than 3% or more of the issued share capital of the Company
|Name||Number of Shares|
|Lansdowne Partners Limited||19,060,500||26.9%|
|Point72 Asset Management||4,006,155||5.7%|
|Hargreave Hale Limited||2,921,500||4.1%|
Information reviewed on 17 November 2017